Health
BAT’s COVID-19 vaccine candidate gets FDA approval for human study – Reuters
British American Tobacco, the maker of Dunhill and Lucky Strike cigarettes, said on Wednesday its COVID-19 vaccine candidate was approved by the U.S. Food and Drug…
By Reuters Staff
Dec 16 (Reuters) – British American Tobacco, the maker of Dunhill and Lucky Strike cigarettes, said on Wednesday its COVID-19 vaccine candidate was approved by the U.S. Food and Drug Administration for Phase I human study.
The Worlds No.2 cigarette company had earlier this year said it was working on a COVID-19 vaccine using proteins extracted from tobacco leaves.
The company said the enrolment for the study is expected to begin shortly.
-
Noosa News23 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
General16 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News16 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
Noosa News23 hours agoFrank Moneger identified as man accused of hit-and-run death of 17-year-old girl in Margate, Queensland